A two-week Clinical pharmacokinetics/pharmacodynamics research course focusing on HIV/AIDS antimalarial drug therapy has opened at the College of Health Sciences. The course has participants from Uganda and Sweden.Ôö¼├í
Speaking at the opening ceremony, the Head of the Department of Pharmacology and Therapeutics Associate Professor Paul Waako, said that the Makerere University-Karolinska Institutet collaboration is expanding to other directions other than PhD studies.
The Dean, School of Biomedical Sciences, Associate Professor Charles Ibingira said the school is trying to improve its image by strengthening academics. He said that the course will help improve the knowledge of the students, most of whom are pursuing Masters and PhD studies.
He expressed hope that in future the course will attract more international participants and a lot more local ones.
The Deputy Principal, Makerere University College of Health Sciences, Professor Celestino Obua, said Makerere University is one of the prime and potential academic institutions in Africa with a good ranking outside South Africa and Cairo. Ôö¼├íHe said the University is attracting many more collaborations including from African institutions. He said the Karolinska Institutet collaboration alone has produced close to fifty (50) PhD degrees, majority of which are in the College of Health Sciences. He encouraged the course participants to initiate discussion and not just sit to be taught.
Professor Lars Gustafsson from Karolinska Institutet said the collaboration between the two institutions is a priority one for Karolinska Institutet. Ôö¼├í